Freemont Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Buy |
8,600
+2,000
| +30% | +$371K | 0.24% | 75 |
|
|
2025
Q1 | $1.38M | Sell |
6,600
-600
| -8% | -$126K | 0.45% | 62 |
|
|
2024
Q4 | $1.28M | Hold |
7,200
| – | – | 0.56% | 55 |
|
|
2024
Q3 | $1.42M | Hold |
7,200
| – | – | 0.7% | 46 |
|
|
2024
Q2 | $1.23M | Sell |
7,200
-35,800
| -83% | -$6.14M | 0.58% | 40 |
|
|
2024
Q1 | $7.83M | Sell |
43,000
-13,300
| -24% | -$2.42M | 1.12% | 29 |
|
|
2023
Q4 | $8.72M | Hold |
56,300
| – | – | 1.1% | 29 |
|
|
2023
Q3 | $8.39M | Sell |
56,300
-9,500
| -14% | -$1.42M | 1.25% | 25 |
|
|
2023
Q2 | $8.87M | Hold |
65,800
| – | – | 1.07% | 31 |
|
|
2023
Q1 | $10.5M | Hold |
65,800
| – | – | 1.47% | 20 |
|
|
2022
Q4 | $10.6M | Hold |
65,800
| – | – | 1.67% | 20 |
|
|
2022
Q3 | $8.83M | Sell |
65,800
-1,600
| -2% | -$215K | 1.61% | 17 |
|
|
2022
Q2 | $10.3M | Sell |
67,400
-3,400
| -5% | -$521K | 1.78% | 17 |
|
|
2022
Q1 | $11.5M | Buy |
+70,800
| New | +$11.5M | 1.73% | 13 |
|
|
2021
Q4 | – | Sell |
-102,300
| Closed | -$11M | – | 66 |
|
|
2021
Q3 | $11M | Buy |
102,300
+400
| +0.4% | +$43.1K | 1.46% | 22 |
|
|
2021
Q2 | $11.5M | Hold |
101,900
| – | – | 1.65% | 16 |
|
|
2021
Q1 | $11M | Hold |
101,900
| – | – | 1.8% | 17 |
|
|
2020
Q4 | $10.9M | Buy |
+101,900
| New | +$10.9M | 2.03% | 15 |
|